FDA Alert: Immunosuppressant Drugs: Required Labeling Changes
Links shared publicly online about this topic.
- 1,895total visits
FDA Alert: Immunosuppressant Drugs: Required Labeling Changes
View full resource at drugs.com
Tags: Allergy and Immunology, Drug, FDA
Most Recently Shared on July 16, 2009 at 12:40 am By:
FDA Alert - FDA Requires Labeling Changes for Immunosuppressant Drugs - http://bit.ly/10lxj
FDA Drug Safety Communication: New warnings for using gadolinium-based contrast agents in patients with kidney dysfunction
fda.gov — “The U.S. Food and Drug Administration (FDA) is requiring changes in the drug label for gadolinium-based contrast agents (GBCAs) to minimize the risk of nephrogenic systemic fibrosis (NSF), a rare, but serious, condition associated with the use of GBCAs in certain patients with kidney dysfunction.” View full resource at fda.gov
Most Recently Shared on September 9, 2010 at 11:51 pm By:
HDCN: FDA issues new safety alert re gadolinium-containing contrast agents and NSF. http://bit.ly/9WAYC7
FDA Requires Boxed Warning for Promethazine Hydrochloride Injection
fda.gov — “The U.S. Food and Drug Administration is telling manufacturers of the drug promethazine to include a boxed warning regarding the injectable form of the drug. The warning, under FDA’s authority to require safety labeling changes, will highlight the risk of serious tissue injury when this drug is administered incorrectly. The agency is also alerting health care professionals to the new boxed warning for this product, which is used as a sedative and to treat nausea and vomiting.” View full resource at fda.gov
Most Recently Shared on September 16, 2009 at 3:19 pm By:
eyeonfda Pharma and Health Lawyer
FDA Requires Boxed Warning for Promethazine Hydrochloride Injection http://bit.ly/Fwp4s
Medical News: FDA Wants Stronger Warnings on Immunosuppressants - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA will require some immunosuppressant drug manufacturers to update product labels to reflect increased infection risk, an FDA release said today.” View full resource at medpagetoday.com
Most Recently Shared on July 14, 2009 at 8:57 pm By:
FDA Wants Stronger Warnings on Immunosuppressants http://ow.ly/15HK0s
FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants
fda.gov — “The U.S. Food and Drug Administration today said that it will require manufacturers of some immunosuppressant drugs used in kidney (renal) transplantation to update their labeling to reflect an increased risk of infections.” View full resource at fda.gov
Most Recently Shared on July 14, 2009 at 4:05 pm By:
eyeonfda Pharma and Health Lawyer
FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants http://bit.ly/40cOo
Advertisement
